Post-transcriptional regulation of urokinase-type plasminogen activator receptor expression in lipopolysaccharide-induced acute lung injury

American Journal of Respiratory and Critical Care Medicine

Volumn 179, Issue 4, 2009, Pages 288-298

  Bhandary, Yashodhar P ^a   Velusamy, Thirunavukkarasu ^a   Shetty, Praveenkumar ^a   Shetty, Rashmi S ^a   Idell, Steven ^a   Cines, Douglas B ^b   Jain, Deepika ^b   Bdeir, Khalil ^b   Abraham, Edward ^c   Tsuruta, Yuko ^c   Shetty, Sreerama ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

LPS; Tyrosine phosphorylation; Urokinase type plasminogen activator; Urokinase type plasminogen activator receptor

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C; LIPOPOLYSACCHARIDE; PHOSPHATE BUFFERED SALINE; PHOSPHOGLYCERATE KINASE; UROKINASE; UROKINASE RECEPTOR; MESSENGER RNA; PLAUR PROTEIN, MOUSE; TYROSINE;

3' UNTRANSLATED REGION; ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG INFECTION; MORTALITY; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SEPSIS; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; WILD TYPE; ANIMAL; CHEMICALLY INDUCED DISORDER; CULTURE TECHNIQUE; DISEASE MODEL; ENZYMOLOGY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOBLOTTING; METABOLISM; METHODOLOGY; PROTEIN PROCESSING; RESPIRATORY TRACT MUCOSA; TRANSGENIC MOUSE;

ACUTE LUNG INJURY; ANIMALS; CELL CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; LIPOPOLYSACCHARIDES; MICE; MICE, TRANSGENIC; PHOSPHOGLYCERATE KINASE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RESPIRATORY MUCOSA; RNA, MESSENGER; TYROSINE;

EID: 60749092483     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200712-1787OC     Document Type: Article

References (49)

1. Kollef MH, Schuster DP. The acute respiratory distress syndrome. N Engl J Med 1995;332:27-37.
2. Karen EW, Martha SC, Huang CT, Steven GS, Stephen PK, Claude AP. Bacterial priming increases lung injury in gram-negative sepsis. Am J Respir Crit Care Med 1998;158:610-619.
3. Abraham E, Matthay MA, Dinarello CA, Vincent JL, Cohen J, Opal SM, Glauser M, Parsons P, Fisher CJ Jr, Repine JE. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med 2000;28:232-235.
4. Miller EJ, Cohen AB, Matthay MA. Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis. Crit Care Med 1996;24:1448-1454.
5. Manthous CA. ARDS redux. Clinical Pulmonary Medicine 2006;3:121-127.
6. Abraham E, Gyetko MR, Kuhn K, Arcaroli J, Strassheim D, Park JS, Shetty S, Idell S. Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation. J Immunol 2003; 170:5644-5651.
7. Braat EA, Nauland U, Dooijewaard G, Rijken DC. A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluids. Thromb Haemost 1996;75:908.
8. Philippe J, Offner F, Declerck PJ, Leroux-Roels G, Vogelaers D, Baele G, Collen D. Fibrinolysis and coagulation in patients with infectious disease and sepsis. Thromb Haemost 1991;65:291.
9. Biemond BJ, Levi M, TenCate H. Plasminogen activator and plasmin-ogen activator inhibitor release during experimental endotoxemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades. Clin Sci (Lond) 1995;88:587-594.
10. Levi M, Schultz MJ, Rijneveld AW, van der Poll T. Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. Crit Care Med 2003;31:S238-S242.
11. yetko MR, Sud S, Kendall T, Fuller JA, Newstead MW, Standiford TJ. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J Immunol 2000;165:1513-1519.
12. Shetty S, Kumar A, Johnson AR, Pueblitz S, Idell S. Urokinase receptor in malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis. Am J Physiol 1995;268(6 pt 1):L972-L982.
13. Shetty S. Regulation of urokinase receptor mRNA stability by hnRNPC in lung epithelial cells. Mol Cell Biochem 2005;272:107-118.
14. Sitrin RG, Shollenberger SB, Strieter RM, Gyetko MR. Endogenously produced urokinase amplifies tumor necrosis factor-a secretion by THP-1 mononuclear phagocytes. JLeukocBiol1996;59:302-311.
15. Chapman HA. Plasminogen activators, integrins and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 1997;9: 714-724.
16. Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 2002;3:932-943.
17. May AE, Kanse SM, Lund LR, Gisler RH, Imho FBA, Preissner KT. Urokinase receptor (CD87) regulates leukocyte recruitment via p2 integrins in vivo. J Exp Med 1998;188:1029-1037.
18. Gyetko MR, Chen GH, McDonald RA, Goodman R, Huffnagle GB, Wilkinson CC, Fuller JA, Toews GB. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans:a murine transgenic model. J Clin Invest 1996;97:1818-1826.
19. Mondino A, Blasi F. uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol 2004;25:450-455.
20. Coleman JL, Benach J. The urokinase receptor can be induced by Borrelia burgdorferi through receptors of the innate immune system. Infect Immun 2003;71:5556-5564.
21. Greenberg ME, Belasco JG. Control of the decay of labile protooncogene and cytokine mRNAs. In: Belasco J, Brewerman G, editors. Control of messenger RNA stability. New York: Academic Press; 1993. pp. 199-218.
22. Shetty S, Kumar A, Johnson AR, Pueblitz S, Holiday D, Raghu G, Idell S. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs. Am J Respir Cell Mol Biol 1996;15:78-87.
23. Shetty S, Kumar A, Idell S. Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol Cell Biol 1997;17: 1075-1083.
24. Shetty S, Idell S. Urokinase receptor mRNA stability involves tyrosine phosphorylation in lung epithelial cells. Am J Respir Cell Mol Biol 2004;30:69-75.
25. Shetty S, Muniyappa H, Halady PK, Idell S. Regulation of urokinase receptor expression by phosphoglycerate kinase. Am J Respir Cell Mol Biol 2004;31:100-106.
26. Parsey MV, Tuder R, Abraham E. Neutrophils are major contributors to intraparenchymal lung IL-1 b expression after hemorrhage and endotoxemia. J Immunol 1998;160:1007.
27. Shenkar R, Abraham E. Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: roles of reactive oxygen intermediates, NF-κB, and CREB. J Immunol 1999;163:954-962.
28. Shetty S, Idell S. Urokinase induces expression of its own receptor in Beas2B lung epithelial cells. J Biol Chem 2001;276:24549-24556.
29. Shetty S, Velusamy T, Idell S, Tang H, Shetty P. Regulation of urokinase receptor expression by protein tyrosine phosphatases. Am J Physiol Lung Cell Mol Physiol 2007;292:L414-L421.
30. Bortnick AE, Favari E, Tao JQ, Francone OL, Reilly M, Zhang Y, Rothblat GH, Bates SR. Identification and characterization of rodent ABCA1 in isolated type II pneumocytes. Am J Physiol Lung Cell Mol Physiol 2003;285:L869-L878.
31. Warshamana GS, Corti M, Brody AR. TNF-α, PDGF, and TGF-β(1) expression by primary mouse bronchiolar-alveolar epithelial and mesenchymal cells: TNF-α induces TGF-β(1). Exp Mol Pathol 2001;71:13-33.
32. Shetty S, Idell S. A urokinase receptor mRNA binding protein from rabbit lung fibroblasts and mesothelial cells. Am J Physiol Lung Cell Mol Physiol 1998;274:871-882.
33. Lund LR, Ronne E, Roldan AL, Behrendt N, Romer J, Blasi F, Dano K. Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells. J Biol Chem 1991;263:2358-2363.
34. Lund LR, Ellis V, Ronne E, Pyke C, Dano K. Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549. Biochem J 1995;310:345-352.
35. Mazar AP, Henkin J, Goldfarb RH. The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis. Angiogenesis 1999;3:15-32.
36. Montuori N, Mattiello A, Mancini A, Santoli M, Taglialatela P, Caputi M, Rossi G, Ragno P. Urokinase type plasminogen activator up regulates the expression of its cellular receptor through post tran-scriptional mechanism. FEBS Lett 2001;508:379-384.
37. Shetty S, Kumar A, Johnson A, Idell S. Regulation of mesothelial cell mitogenesis by antisense oligonucleotides for the urokinase receptor. Antisense Res Dev 1995;5:307-314.
38. Bhat GJ, Gunaje JJ, Idell S. Urokinase-type plasminogen activator induces tyrosine phosphorylation of a 78-kDa protein in H-157 cells. Am J Physiol 1998;277:L301-L309.
39. Idell S, Kumar A, Zwieb C, Holiday D, Koenig KB, Johnson AR. Effects of TGF-β and TNF-α on procoagulant and fibrinolytic pathways of human tracheal epithelial cells. Am J Physiol 1994;267:L693-L703.
40. Xing RH, Mazar A, Henkin J, Rabbani SA. Prevention of breast cancer growth, invasion, and metastasis by anti-estrogen tamoxifen alone or in combination with urokinase inhibitor B-428. Cancer Res 1997;57: 3585-3593.
41. Wang GJ, Collinge M, Blasi F, Pardi R, Bender JR. Human urokinase receptor expression is inhibited by amiloride and induced by tumor necrosis factor and phorbol ester in colon cancer. Proc Natl Acad Sci USA 1998;95:6296-6301.
42. Kitamura Y, Hashimoto S, Mizuta N, Kobayashi A, Kooguchi K. Fas/ FasL-dependent apoptosis of alveolar cells after lipopolysaccharide- induced lung injury in mice. Am J Respir Crit Care Med 2001;163: 762-769.
43. Matute-Bello G, Winn RK, Martin TR, Liles WC. Sustained lipopoly-saccharide-induced lung inflammation in mice is attenuated by functional deficiency of the Fas/Fas ligand system. Clin Diagn Lab Immunol 2004;11:358-361.
44. Rojas M, Woods CR, Mora AL, Xu J, Brigham KL. Endotoxin-induced lung injury in mice: structural, functional, and biochemical responses. Am J Physiol Lung Cell Mol Physiol 2005;288:L333-L341.
45. Altemeier WA, Matute-Bello G, Gharib SA, Glenny RW, Martin TR. Modulation of lipopolysaccharide-induced gene transcription and promotion of lung injury by mechanical ventilation. J Immunol 2005; 175:3369-3376.
46. Gharib SA, Liles WC, Matute-Bello G, Glenny RW, Martin TR. Computational identification of key biological modules and transcription factors in acute lung injury. Am J Respir Crit Care Med 2006;173:653-658.
47. Shetty S, Khalil B, Cines DB, Idell S. Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells. J Biol Chem 2003;278: 18124-18131.
48. Lau HK, Ho J. Regulation of plasminogen activator inhibitor-1 secretion by urokinase and tissue plasminogen activator in rat epithelioid type smooth muscle cells. Br J Haematol 2002;117:151-155.
49. Han J, Lee JD, Tobias PS, Ulevitch RJ. Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J Biol Chem 1993;268:25009-25014.